Travere Therapeutics (TVTX) P/E (2013 - 2026)
Travere Therapeutics (TVTX) P/E from Jul 1, 2013 to Jul 21, 2026. The TTM Travere Therapeutics (TVTX) P/E is -249.07. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Travere Therapeutics (TVTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -249.07 | +89.06% |
| 2025 | -131.74 | +3001.63% |
| 2024 | -4.25 | -194.08% |
| 2023 | 4.51 | -189.25% |
| 2022 | -5.06 | -52.03% |
| 2021 | -10.55 | +26.26% |
| 2020 | -8.35 | +104.20% |
| 2019 | -4.09 | -54.48% |
| 2018 | -8.99 | -43.88% |
| 2017 | -16.01 | -6.09% |
| 2016 | -17.05 | -389.42% |
| 2015 | 5.89 | -313.48% |
| 2014 | -2.76 | -60.46% |
| 2013 | -6.98 | N/A |
Comparison Travere Therapeutics (TVTX) P/E with competitors
Travere Therapeutics (TVTX) P/E is -249.07.